A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's
Clinical trial NCT01148498 · COMPLETED
Trial details
- NCT number
- NCT01148498
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2012-08-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.